Exodus Point Capital Management, LP Adamis Pharmaceuticals Corp Transaction History

Exodus Point Capital Management, LP

  • $14.7 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$1.26 - $2.23 $80,926 - $143,226
-64,227 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$2.02 - $3.22 $105,498 - $168,170
52,227 Added 435.23%
64,227 $136,000
Q4 2018

Feb 14, 2019
BUY
$2.1 - $3.21 $25,200 - $38,520
12,000 New
12,000 $27,000

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track This Portfolio

Track Exodus Point Capital Management, LP Portfolio

Follow Exodus Point Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email